Vice President, US Market Access Lead - Oncology

Oncology Access Strategy

Develop and maintain a fully integrated brand market access plan for all oncology brands, covering payer marketing, contracting strategy, and pricing strategy in one coherent plan.
Translate portfolio-level access priorities into brand-specific execution plans, ensuring consistency across franchise teams and alignment with enterprise GTN objectives.
Define payer value propositions, messaging, and positioning for Oncology brands in partnership with access marketing resources.
Ensure brand-level pricing and contracting strategies optimize net trade sales and gross-to-net outcomes across payer, GPO, and channel.
Define and monitor access performance metrics at the brand and portfolio level, including access quality, access speed, GTN performance, and launch readiness.
Periodically reassess and reallocate brand-level resources across the Oncology portfolio based on lifecycle stage, launch timing, and business priority.
Proactively adjust access plans in response to external environment shifts, including IRA drug pricing dynamics, 340B evolution, PBM-payer consolidation, and formulary changes.

BU Partnership & Representation

Serve as the single point of communication and accountability between USMAPPS and the Oncology BU President and franchise leads for all access, contracting strategy, and payer marketing needs.
Sit on the Oncology BU leadership team as primary USMAPPS advisor to franchise leads, operating as a strategic partner rather than a transactional interface.
Represent Oncology BU access needs back into USMAPPS leadership, escalating resource gaps, strategic misalignment, or unresolved cross-functional tensions.
Partner with Oncology BU franchise leads to understand brand P&L objectives and translate these into specific access, contracting, and payer marketing priorities.
Flag trade-offs between revenue maximization and GTN discipline to BU and USMAPPS leadership, ensuring enterprise-level decision-making rather than brand-pressure-driven discounting.
Proactively socialize USMAPPS access capabilities and strategic intent with Oncology BU leadership to build trust and reduce friction at the interface.
Drive a cultural reset within the BU interface toward proactive cross-functional collaboration, strategic ownership mindset, and enterprise-level decision-making.

Launch Readiness

Own the access chapter of the strategic brand plan for all Oncology pipeline assets, ensuring access strategy is fully integrated into brand planning from early lifecycle stages.
Identify and close access readiness gaps, including payer coverage, specialty pharmacy pull-through, reimbursement pathways, and formulary positioning, aligned to brand archetype and launch objectives.
Establish and track launch access KPIs in partnership with Strategic Account Management, brand teams, and customer engagement teams.
Define 3-year market access plans for pipeline assets, incorporating GTN inputs into long-range financial planning.

Team Leadership & Talent

Lead and develop a team aligned to Oncology brands and franchise clusters, driving execution through the team while maintaining personal accountability for brand-level access outcomes and deliverables.
Coach and develop team members to operate as strategic owners with clear accountability for outputs, not coordinators or traffic managers.
Partner with Oncology BU President and franchise leads to identify strong internal candidates for team roles and pursue external sourcing where internal talent is not available.
Create clear career development pathways within Oncology, access vertical to build a sustainable talent pipeline within USMAPPS.
Participate as a core member of the USMAPPS Leadership Team, contributing to enterprise strategy and cross-functional alignment.
Model Pfizer values and leader behaviors.